Clin2
NCT07344506Possibly a fitRecruiting

Cure H. pylori: New combination therapy for stomach infection

H. Pylori Gastrointestinal DiseaseH.Pylori InfectionH.Pylori Eradication Rate

Part of Digestive system clinical trials.

This trial tests a new combination of medications to treat H. pylori, a common stomach infection that can cause ulcers. It aims to find a more effective treatment with fewer side effects.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
942 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You must be an adult (18 years or older).
  • You must have been diagnosed with H. pylori infection using a breath test.
  • You cannot be currently taking any treatment for H. pylori.
  • You must not have taken any antibiotics in the last two weeks.
  • You must not be pregnant or breastfeeding.
  • You must not have any known allergies to the study medications.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07875933Not yet recruiting· Phase 3
Triple therapy for H. pylori infection

This study tests a new combination of three medicines to treat H. pylori, a stomach bacteria that can cause ulcers. If you have H. pylori and have not been treated for it before, this trial might help you get rid of the infection.

NCT07624422Not yet recruiting· Phase 4
Helicobacter pylori infection treatment study

This study tests a new antibiotic combination to treat stomach infections caused by H. pylori bacteria. It may help clear the infection and reduce stomach problems.

Damascus
NCT07537634Recruiting· Phase 4
New stomach acid medicine versus standard treatment for H. pylori infection

This trial compares two different antibiotic combinations to treat H. pylori, a common stomach bacteria that causes indigestion and ulcers. One uses a newer acid-blocking medicine (vonoprazan) and the other uses a standard one (esomeprazole), both paired with antibiotics.

Dhaka
NCT07115173Not yet recruiting· Phase 4
Triple therapy for h. pylori infection

This study tests a three-drug combination (called triple therapy) to get rid of H. pylori, a bacteria that can cause stomach problems like ulcers and inflammation. If you have H. pylori and one of the listed stomach conditions, this treatment might help clear the infection.

NCT06959368Recruiting· Phase 4
New H. pylori treatment vs standard triple therapy

This trial compares a newer drug (vonoprazan) plus antibiotics to the standard triple therapy for eradicating H. pylori infection in the stomach. It may be a good option if you have stomach symptoms like indigestion, acid reflux, or a non-bleeding ulcer and have not been treated for H. pylori before.

Hyderabad, Telangana
NCT07130253Not yet recruiting
New treatment for stubborn H. pylori infection

This trial tests a new combination of medicines to get rid of H. pylori bacteria in people whose previous treatments have not worked. It aims to find a more effective way to clear the infection.

Taipei

Hear when a new H. Pylori Gastrointestinal Disease trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.